BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2014 9:24:00 PM | Browse: 1435 | Download: 1945
Publication Name World Journal of Gastroenterology
Manuscript ID 10785
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Meta-Analysis
Article Title Efficacy and safety of gemcitabine-based combination chemotherapy in advanced biliary tract cancer: A meta-analysis
Manuscript Source Unsolicited Manuscript
All Author List Heng Liu, Qi-Di Zhang, Zheng-Hong Li, Qing-Qing Zhang and Lun-Gen Lu
Funding Agency and Grant Number
Corresponding Author Lun-Gen Lu, MD, Professor, Chief, Department of Gastroenterology, Shanghai First People’s Hospital, Shanghai Jiao Tong University School of Medicine, No. 100 Haining Road, Hongkou District, Shanghai 200080, China. lungenlu1965@163.com
Key Words Biliary tract cancer; Combination chemotherapy; Gemcitabine; Meta-analysis; Randomized trial
Core Tip In this meta-analysis, we evaluated the efficacy and safety of gemcitabine-based combination chemotherapy compared with other regimens for the treatment of advanced BTC. Seven randomized trials were selected and included in the final analysis. The overall analyses revealed that patients treated with Gem-based combination chemotherapy had significantly higher DRR, a longer PFS and a longer OS. A higher incidence of grade 3-4 hematological toxicities: including leukopenia, anemia, neutropenia in the Gem-based combination chemotherapy group compared with the Gem monotherapy or non-Gem-based chemotherapy group. However, all severe hematological toxicities are infrequent and reversible. Therefore, Gem-based combination chemotherapy should be considered a standard first-line treatment for advanced BTC.
Publish Date 2014-12-20 19:42
Citation Liu H, Zhang QD, Li ZH, Zhang QQ, Lu LG. Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18001-18012
URL http://www.wjgnet.com/1007-9327/full/v20/i47/18001.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i47.18001
Full Article (PDF) WJG-20-18001.pdf
Full Article (Word) WJG-20-18001.doc